FDA approves OraSure's hepatitis C test

06/27/2010 | Reuters

OraSure Technologies announced that it secured FDA approval for OraQuick, a test that can spot antibodies to the hepatitis C virus using a patient's blood sample. An analyst for Needham & Co. said the FDA could approve an oral fluid test version of the company's OraQuick this year.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC